Meningococcal Meningitis (Neisseria meningitidis)
Presentation :
- Meningitis w/ fever, headache, meningismus, nausea, vomiting, photophobia.
- Maculopapular or hemorrhagic petechial rash often appears soon after disease onset
- Waterhouse-Friderichsen syndrome: septicemia w/ b/l adrenal hemorrhage leading to adrenal crisis profound shock, cutaneous purpura (can occur in other infxn as well)
Pathophysiology :
- Infection is spread by direct contact with nasal and throat secretions, so typically spreads to very close contacts: household contacts, dormitory/barrack residents (college students, military), healthcare workers, etc
- Meningococci can asymptomatically colonize the nasopharynx (carrier state). Despite documented high rates of colonization (5 to 40% of healthy people), which may be transient, brief, or prolonged, transition to invasive disease is rare (< 1%)
- Nasopharyngeal carriage rates are highest in adolescents and young adults, who serve as reservoirs for transmission of N. meningitidis
- Encapsulated bacteria, so asplenic patients at much higher risk
Diagnostic Testing:
Treatment :
- Empiric covg w/ standard meningitis abx (CTX, Vanc +/- Ampicillin for immunocompromise or age >50)
- Once confirmed: Ceftriaxone 2 g IV every 12 hours is preferred treatment
- Can use Penicillin IV, however resistance is emerging, and pts require retreatment w/ CTX, cipro or rifampin to eliminate nasopharyngeal carriage
- If suspicion for Waterhouse-Friderichsen syndrome w/ adrenal insufficiency, can consider hydrocortisone
- Evidence does not support usage for treatment of meningitis alone, and steroids may worsen meningococcal shock
-
Prophylaxis for close contacts:
- Rifampin 600mg PO q12h x4 doses
- Ceftriaxone 250mg IM x1 dose
- Ciprofloxacin/Levofloxacin 500mg PO x1d (resistance emerging; likely not ideal 1st line)
-
Vaccination:
- MenACWY conjugate:
- Routine childhood vaccine (~age 11-12, booster at 16)
- College students who missed booster at 16
- High risk adults: anatomic/functional asplenia, HIV, complement deficiency or inhibitor use, military recrtuits, travel to endemic areas (see CDC for complete list)
- MenB:
- High risk patients (as above)
- If pt requests per shared decision making
- MenACWY conjugate:
Prognosis:
References:
Created on: Tuesday 08-15-2023